Our Transactions
Leadership across the largest and most complex situations
Advising
on the separation of its Biosciences & Diagnostics Solutions business
2025
Lead Financial Advisor
on its pending ~$26.6 billion sale to
2025
Advising
on its $5.1 billion
sale to
2024
Lead Left Bookrunner
$2.6 billion
Follow-on Offering
2024
Financial Advisor
on its $22.5 billion
acquisition of
2024
Sole Financial Advisor
Ad Hoc Group of First Lien Creditors on
chapter 11 restructuring of $8.1 billion of debt
2024
Lead Financial Advisor
on its €8.0 billion
acquisition of
from Vodafone Group
2024
Advised
on its ~$2.3 billion
acquisition of
2024
Independent Financial Advisor
on its acquisition of three fill-finish sites for an upfront payment of $11 billion from Novo Holdings following its $16.5 billion acquisition of Catalent
2024
Exclusive Financial Advisor
on its pending ~$35 billion
acquisition of
2024
Exclusive Financial Advisor
on its ~$12.6 billion
sale to
2024
Lead Financial Advisor
on its $11.5 billion
all-stock merger with
2024
Anouncement Date1 |
Status |
Transaction |
Value (M) |
---|---|---|---|
December 27, 2023 |
Closed |
Advised Hartree on the sale of Gulf Coast Natural Gas Storage Assets to Williams |
$1,950 |
December 21, 2023 |
Closed |
Advised MeiraGTx on its asset purchase agreement with Janssen Pharmaceuticals |
Up to $415 |
December 21, 2023 |
Closed |
Acted as Sole Bookrunning Manager on Shattuck Labs' Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants |
~$50 |
December 20, 2023 |
Closed |
Advised NFP on its sale to Aon |
~$13,400 |
December 20, 2023 |
Closed |
Acted as Sole Structuring Advisor and Sole Bookrunner on the issuance of Thrivent Financial’s Collateralized Fund Obligation Class A Notes |
$400 |
December 20, 2023 |
Closed |
Advised Leonard Green & Partners on the closing of a Continuation Fund to acquire four portfolio companies across Green Equity Investors VI and and Green Equity Investors VII |
$2,200 |
December 18, 2023 |
Pending |
Advising U.S. Steel on its sale to Nippon Steel |
~$14,900 |
December 14, 2023 |
Closed |
Advised EnergySource Minerals on the sale of a minority stake in its technology subsidiary, ILiAD Technologies, to Livent Corporation |
N/A |
December 13, 2023 |
Pending |
Advising Lunit on its acquisition of Volpara Health |
~AU$296 |
December 13, 2023 |
Closed |
Advised TMX Group on its acquisition of the remaining equity in VettaFi |
$848 |
December 8, 2023 |
Pending |
Advising Honeywell on its acquisition of the Global Access Solutions business of Carrier Global Corporation |
$4,950 |
December 6, 2023 |
Closed |
Advised SSW Partners on its sale of Veoneer Restraint Control Systems to American Industrial Partners |
N/A |
December 1, 2023 |
Closed |
Advised J-STAR on the closing of its Continuation Series Funds |
~¥30,000 |
November 29, 2023 |
Closed |
Acted as Lead Financial Advisor to Blackstone on its acquisition of Rover |
$2,300 |
November 28, 2023 |
Closed |
Acted as Exclusive Global Advisor to Antin for the fundraise of Antin NextGen Infrastructure Fund I |
€1,200 |
November 16, 2023 |
Closed |
Advised HanesBrands on its settlement and cooperation agreement with shareholder Barington Capital |
N/A |
November 16, 2023 |
Closed |
Advised Eroski on its debt refinancing and high yield capital markets debut |
€1,200 |
November 15, 2023 |
Closed |
Advised Goodyear on its transformation plan – “Goodyear Forward” |
N/A |
November 15, 2023 |
Closed |
Advised LLOG Exploration Offshore on the sale of 30% interest in Who Dat and Dome Patrol oil and gas fields and associated infrastructure along with interest in adjacent exploration acreage to Karoon Energy Limited |
$720 |
November 15, 2023 |
Closed |
Advised Searchlight Capital Partners on a single-asset continuation fund for Integrated Power Services |
N/A |
November 15, 2023 |
Closed |
Acted as Lead Left Bookrunner on Augmedix’s Follow on Offering |
$28 |
November 14, 2023 |
Closed |
Advised DSD Renewables on its strategic investment from Cox Enterprises |
$250 |
November 14, 2023 |
Closed |
Advised Paradox Resources on the sale of its assets to GNG Partners following Chapter 11 Bankruptcy |
N/A |
November 13, 2023 |
Closed |
Advised the Conflicts Committee of the Board of Directors of Capital Product Partners on its acquisition of 11 LNG Carriers from Capital Maritime |
$3,130 |
November 13, 2023 |
Closed |
Advised GenNx360 Capital Partners on the formation of a single-asset continuation fund for Precision Aviation Group |
~$400 |
November 13, 2023 |
Closed |
Acted as the Asian placement agent for the fundraise of PAI Partners VIII |
€7,100 |
November 11, 2023 |
Pending |
Advising TransDigm on its acquisition of Communications & Power Industries’ Electron Device Business from The Jordan Company |
$1,385 |
November 9, 2023 |
Pending |
Advising the Conflicts Committee of Calumet Specialty Products Partners, L.P. on its Partnership Restructuring Agreement and the elimination of its 2.0% general partner interest and incentive distribution rights |
~$75 |
November 9, 2023 |
Pending |
Advising SitusAMC on the sale of its commercial real estate valuation and advisory services business to Altus Group |
$225 |
November 8, 2023 |
Closed |
Advised Nordic Capital on its acquisition of a majority share in IntegriChain |
N/A |
November 8, 2023 |
Closed |
Acted as a Joint Bookrunner on CCC Intelligent Solution's Follow-on Offering |
~$734 |
November 6, 2023 |
Closed |
Acted as an Active Bookrunner on Aura Biosciences’ Follow-on Offering |
~$99 |
November 3, 2023 |
Closed |
Advised the Ad Hoc Group of EVPS term loan lenders on Envision Healthcare’s Chapter 11 Restructuring |
~$7,500 |
November 1, 2023 |
Pending |
Advising Digital Realty on the sale of data center assets to Brookfield and acquisition of data center leases from Cyxtera |
~$500 |
November 1, 2023 |
Closed |
Advised Cureton Midstream on the sale of its DJ Basin gathering and processing assets to The Williams Companies |
$560 |
October 31, 2023 |
Pending |
Advising Vodafone on its sale of Vodafone Spain to Zegona |
€5,000 |
October 30, 2023 |
Closed |
Advised MeiraGTx on its strategic investment from Sanofi |
$30 |
October 30, 2023 |
Closed |
Acted as a Lead Placement Agent on Viridian Therapeutics’ Private Placement Financing |
$185 |
October 25, 2023 |
Closed |
Acted as exclusive global placement agent to Parcom on the closing of its seventh fund |
€960 |
October 24, 2023 |
Closed |
Advised Powin on its majority sale of EKS to Hitachi |
N/A |
October 24, 2023 |
Closed |
Advised Keyfactor on its significant minority investment from Sixth Street |
$1,300 |
October 24, 2023 |
Closed |
Advised the Ad Hoc Group of First Lien Term Loan Lenders on Air Methods’ Prepackaged Chapter 11 Bankruptcy |
~$2,200 |
October 24, 2023 |
Closed |
Advised Powin on its majority sale of EKS to Hitachi |
N/A |
October 24, 2023 |
Closed |
Advised Keyfactor on its significant minority investment from Sixth Street |
$1,300 |
October 23, 2023 |
Closed |
Advised the Special Committee of the Board of EngageSmart on its sale to Vista Equity Partners |
~$4,000 |
October 23, 2023 |
Pending |
Advising Chevron on its acquisition of Hess |
~$60,000 |
October 20, 2023 |
Pending |
Advising Onex on its acquisition of Accredited from R&Q |
$465 |
October 20, 2023 |
Closed |
Advised Bamboo on its majority investment from White Mountains |
~$285 |
October 20, 2023 |
Closed |
Advised Alpine Investors on the acquisition of equity interests in Apex Service Partners through a single-asset continuation fund |
$465 |
October 13, 2023 |
Closed |
Advised Amphenol on its acquisition of PCTEL |
~$140 |
October 13, 2023 |
Closed |
Advised SunOpta on the sale of its frozen fruit business to Nature’s Touch |
$141 |
October 12, 2023 |
Closed |
Advised Comtech on the sale of its Power Systems Technology product line to Stellant |
Up to $40 |
October 11, 2023 |
Closed |
Advised the Ad Hoc Group of First Lien Term Loan lenders on Invited’s comprehensive Amend & Extend transaction |
$1,100 |
October 11, 2023 |
Closed |
Advised Spin Master on its acquisition of Melissa & Doug |
$950 |
October 11, 2023 |
Closed |
Acted as an Active Bookrunner on Astria Therapeutics’ Underwritten Equity Offering |
$64 |
October 10, 2023 |
Closed |
Advised an Ad Hoc Group of First Lien Term Lenders on Mallinckrodt’s Prepackaged Chapter 11 Restructuring |
$3,500 |
October 10, 2023 |
Closed |
Acted as Joint Bookrunner on Birkenstock’s initial public offering |
$1,484 |
October 8, 2023 |
Closed |
Advised Bristol Myers Squibb on its acquisition of Mirati |
Up to ~$5,800 |
October 4, 2023 |
Closed |
Advised Exus Management Partners on its sale to Partners Group |
N/A |
October 3, 2023 |
Closed |
Advised CommScope on the sale of its Home Networks Business to Vantiva |
N/A |
October 3, 2023 |
Closed |
Advised Sugar Foods on its sale to Pritzker Private Capital |
N/A |
October 2, 2023 |
Closed |
Advised Pretium Packaging on its new debt financing and open market repurchase of existing debt |
$1,625 |
September 28, 2023 |
Closed |
Acted as Active Bookrunner on Madrigal Pharmaceuticals’ Follow-on Offering |
~$500 |
September 27, 2023 |
Closed |
Advised Virgin Pulse on its merger with HealthComp |
N/A |
September 27, 2023 |
Closed |
Advised Xeris on its Private Convertible Note Exchange |
~$34 |
September 18, 2023 |
Closed |
Advised the Conflicts Committee of the General Partner of Green Plains Partners LP on its sale to Green Plains Inc. |
N/A |
September 18, 2023 |
Closed |
Advised Schroders Greencoat and Swiss Life Asset Management on their acquisition of UK district heating and cooling assets from Bouygues |
~£270 |
September 14, 2023 |
Closed |
Acted as an Active Bookrunner on RayzeBio’s initial public offering |
$358 |
September 12, 2023 |
Pending |
Advising the Board of Directors of WestRock on its merger with Smurfit Kappa |
~$33,500 |
September 12, 2023 |
Closed |
Acted as a Joint Bookrunner on Granite Ridge Resources’ Follow-on Offering |
$41 |
September 11, 2023 |
Closed |
Acted as Joint Bookrunner on AerCap’s secondary public offering of its ordinary shares by General Electric |
~$2,760 |
September 7, 2023 |
Closed |
Advised Precision Drilling on its acquisition of CWC Energy Services |
~$141 |
September 6, 2023 |
Pending |
Advising Commercial Trailer Leasing on its sale to I Squared Capital |
N/A |
September 6, 2023 |
Closed |
Acted as an Active Bookrunner on Crescent Energy’s Follow-on Offering |
$155 |
September 5, 2023 |
Closed |
Advised Viper Energy on its acquisition of certain mineral and royalty interests from Warwick Capital and GRP Energy |
~$1,000 |
September 5, 2023 |
Closed |
Advised Caledonia on its sale of 7iM to Ontario Teachers’ Pension Plan |
N/A |
September 5, 2023 |
Closed |
Advised Clearpath Robotics on its sale to Rockwell Automation |
N/A |
September 5, 2023 |
Closed |
Advised Ascendis on its synthetic royalty funding agreement with Royalty Pharma |
$150 |
August 29, 2023 |
Closed |
Advised Cognex on its acquisition of Moritex |
¥40,000 |
August 21, 2023 |
Pending |
Advising World Insurance Associates on its investment from Goldman Sachs Asset Management |
~$3,400 |
August 17, 2023 |
Pending |
Advising H&F and TeamSystem on its minority stake sale to ADIA and CapitalG |
N/A |
August 16, 2023 |
Closed |
Advised Crestwood on its sale to Energy Transfer |
~$7,100 |
August 15, 2023 |
Closed |
Acted as an Active Bookrunner on AN2 Therapeutics’ Underwritten Equity Offering |
$70 |
August 14, 2023 |
Closed |
Advised Chesapeake Energy on the sale of its remaining Eagle Ford assets to SilverBow Resources |
$700 |
August 11, 2023 |
Closed |
Advised Anchor Glass Container Corporation on its amendment and maturity extension of its first lien, second lien, and asset-based lending facility debt |
~$830 |
August 10, 2023 |
Closed |
Acted as the Exclusive Financial Advisor to the Special Committee of the Board of Directors of Arco on its sale to General Atlantic and Dragoneer Investment Group |
~$1,500 |
August 9, 2023 |
Pending |
Advising x + bricks on the sale of its grocery-anchored real estate portfolio to Slate Asset Management |
~€1,000 |
August 9, 2023 |
Closed |
Advised Cadent on its sale to Novacap |
N/A |
August 8, 2023 |
Closed |
Acted as the Exclusive Advisor to the Special Committee of the Board of Directors of EchoStar on its merger with DISH Network |
N/A |
August 7, 2023 |
Closed |
Advised Western Global Airlines on its Restructuring via Pre-Arranged Chapter 11 Bankruptcy |
~$515 |
August 7, 2023 |
Closed |
Advised Campbell Soup Company on its acquisition of Sovos Brands |
~$2,700 |
August 7, 2023 |
Closed |
Advised Beacon Rail on its acquisition of Mitsui Rail |
N/A |
August 7, 2023 |
Closed |
Advised Gracell Biotechnologies on its private placement |
Up to $150 |
August 3, 2023 |
Closed |
Acted as Lead Left Bookrunner on QuantumScape’s Follow-on Offering |
$300 |
August 1, 2023 |
Closed |
Advised Texas Pacific Land Corporation on its cooperation agreement with Horizon Kinetics and SoftVest |
N/A |
August 1, 2023 |
Closed |
Advised Bridge Investment Group on the recapitalization of assets from Bridge Multifamily Fund III into a Continuation Fund |
~$550 |
July 31, 2023 |
Closed |
Advised Wendel on its sale of Constantia Flexibles to One Rock Capital Partners |
N/A |
July 27, 2023 |
Pending |
Advising the Board of Directors of TC Energy on the spinoff of its Liquids Pipelines business |
N/A |
July 26, 2023 |
Closed |
Advised ib vogt on its financing package underwritten by Santander |
€350 |
July 25, 2023 |
Closed |
Advised Goodyear on its cooperation agreement with Elliott Investment Management |
N/A |
July 24, 2023 |
Closed |
Advised an ad hoc group of Term Loan Lenders and Unsecured Noteholders on U.S. Renal Care’s successful debt exchange |
N/A |
July 21, 2023 |
Pending |
Advising Safran on its acquisition of Collins Aerospace’s actuation and flight control business from Raytheon Technologies |
~$1,800 |
July 20, 2023 |
Closed |
Advised Evertec, Inc. on its acquisition of Sinqia |
~R$2,835 |
July 19, 2023 |
Closed |
Acted as a Bookrunner for Aurora Innovation’s Follow-on Offering |
$253 |
July 17, 2023 |
Closed |
Advised Mirum Pharmaceuticals on its acquisition of Travere Therapeutics’ bile acid product portfolio and concurrent $210mm equity offering |
~$445 |
July 17, 2023 |
Closed |
Advised Gresham House plc on its recommended cash offer by Searchlight Capital Partners |
~£470 |
July 17, 2023 |
Closed |
Advised DTx Pharma on its sale to Novartis |
Up to $1,000 |
July 13, 2023 |
Closed |
Acted as an Active Bookrunner on Caribou’s Follow-On Offering |
~$144 |
July 13, 2023 |
Closed |
Acted as exclusive advisor to CapVest on its acquisition of Kerridge Commercial Systems |
N/A |
July 13, 2023 |
Closed |
Advised Rubicon Technology Partners on its strategic investment in Tacton |
N/A |
July 11, 2023 |
Closed |
Advised Tecomet on its ~$780mm new money 1L TL financing and recapitalization of ~$1bn of debt |
~$1,000 |
July 6, 2023 |
Closed |
Advised GfK on the sale of its Consumer Panel Business to YouGov |
€315 |
July 3, 2023 |
Closed |
Advised Monster Beverage Corporation on its acquisition of Bang Energy |
$362 |
June 30, 2023 |
Closed |
Advised Novartis on the sale of ‘front-of-eye’ ophthalmology assets to Bausch + Lomb |
$1,750 Upfront; +$2,500 after milestones |
June 30, 2023 |
Closed |
Advised Qpex Biopharma, Inc. on its sale to Shionogi & Co. |
$100 Upfront; $140 Total |
June 30, 2023 |
Closed |
Advised an Ad Hoc Group of First Lien Term Loan Lenders on Phoenix Services’ Chapter 11 Restructuring |
~$590 of restructured debt |
June 29, 2023 |
Closed |
Advised Serta Simmons Bedding on its chapter 11 restructuring |
~$1,900 |
June 28, 2023 |
Closed |
Advised ESI Group on the sale of a controlling interest to Keysight Technologies |
~€913 |
June 27, 2023 |
Closed |
Advised the Ad Hoc Group of Digicel International Finance Limited Secured Lenders on Digicel’s Comprehensive Restructuring |
~$4,800 |
June 21, 2023 |
Closed |
Advised Accedian on its sale to Cisco |
N/A |
June 21, 2023 |
Closed |
Advised MSC Industrial on its dual class share recapitalization |
N/A |
June 21, 2023 |
Closed |
Advised Elevate Textiles on its Comprehensive Out-of-Court Restructuring |
N/A |
June 21, 2023 |
Closed |
Acted as an Active Bookrunner on Gulfport Energy Corporation’s Follow-on Offering |
$124 |
June 12, 2023 |
Closed |
Advised Adenza on its sale to Nasdaq |
$10,500 |
June 7, 2023 |
Closed |
Acted as an Active Bookrunner on Mobileye's Follow-on Offering |
$1,617 |
June 7, 2023 |
Closed |
Acted as Lead Left Bookrunner on GE HealthCare's Follow-on Offering |
~$2,200 |
June 7, 2023 |
Closed |
Acted as a Joint Bookrunner on Corebridge's Follow-on Offering |
~$1,100 |
June 7, 2023 |
Closed |
Advised 1010data on its sale to SymphonyAI |
N/A |
June 5, 2023 |
Closed |
Advised CIRCOR on its sale to KKR |
~$1,600 |
May 31, 2023 |
Closed |
Advised CorEnergy on the sale of its MoGas and Omega Pipeline Systems to Spire |
$175 |
May 25, 2023 |
Closed |
Advised Embark and its Transaction Committee on its sale to Applied Intuition |
~$71 |
May 25, 2023 |
Closed |
Advised PureWest Energy on an all-cash merger with Family Office-led Private Consortium |
$1,840 |
May 23, 2023 |
Closed |
Acted as an Active Bookrunner on Phathom Pharmaceuticals' Follow-on Offering |
~$150 |
May 23, 2023 |
Closed |
Acted as Lead Active Bookrunner on Vita Coco's Follow-on Offering |
$132 |
May 22, 2023 |
Closed |
Advised AIG on the sale of Validus Re to RenaissanceRe |
$2,985 |
May 22, 2023 |
Closed |
Advised Chevron on its acquisition of PDC Energy |
~$7,600 |
May 19, 2023 |
Pending |
Advising H&F and TeamSystem on its minority stake sale to Silver Lake |
€600 |
May 17, 2023 |
Closed |
Acted as an Active Bookrunner on Evgo's Follow-on Offering |
~$144 |
May 17, 2023 |
Closed |
Acted as an Active Bookrunner on Gates Industrial Corporation's Follow-on Offering |
~$304 |
May 17, 2023 |
Closed |
Acted as an Active Bookrunner on Cabaletta Bio's Follow-on Offering |
~$100 |
May 17, 2023 |
Closed |
Advised Samsung Display on its acquisition of eMagin |
~$218 |
May 15, 2023 |
Closed |
Advised Cox Communications on its acquisition of full interest in Unite Private Networks |
N/A |
May 9, 2023 |
Closed |
Advised Keeper Security and Insight Partners on Keeper’s minority investment from Summit Partners |
N/A |
May 8, 2023 |
Closed |
Advised the Ad Hoc Group of Lenders on Monitronics’ Prepackaged Chapter 11 Bankruptcy |
~$1,100 |
May 4, 2023 |
Closed |
Acted as an Active Bookrunner on 4D Molecular Therapeutics' Follow-on Offering |
$138 |
May 4, 2023 |
Closed |
Advised Arconic on its sale to Apollo |
$5,200 |
May 3, 2023 |
Closed |
Acted as a placement agent to Dianthus Therapeutics on its concurrent private financing, as part of its reverse merger with Magenta Therapeutics |
$70 |
May 2, 2023 |
Closed |
Advised AIG on its sale of Crop Risk Services to Great American Insurance |
$240 |
April 27, 2023 |
Closed |
Acted as an exclusive global placement agent for the fundraise of Genstar Capital Partners XI |
~$12,600 |
April 26, 2023 |
Closed |
Advised Indicor on its sale of CCC to Honeywell |
$670 |
April 24, 2023 |
Closed |
Advised Medica Group on its sale to IK Partners |
~£269 |
April 21, 2023 |
Closed |
Advised Sureserve Group plc on its acquisition by Cap10 Partners |
~£214 |
April 17, 2023 |
Closed |
Advised Westland Insurance Group on its capital partnership with Ontario Teachers’ Pension Plan |
N/A |
April 17, 2023 |
Closed |
Acted as an Active Bookrunner on Vaxcyte's Follow-on Offering |
$575 |
April 6, 2023 |
Closed |
Advised the Conflicts Committee of the Board of Directors of GasLog Partners on its sale to GasLog Ltd. |
~$1,500 |
April 4, 2023 |
Closed |
Advised Novacap on its acquisition of Static Media |
N/A |
March 24, 2023 |
Closed |
Advised DOF Group on the completion of its comprehensive restructuring |
~$2,400 |
March 23, 2023 |
Closed |
Acted as the Exclusive Financial Advisor to Kredivo Holdings on its Series D equity fundraising round led by Mizuho Bank, Ltd. |
~$270 |
March 22, 2023 |
Closed |
Acted as an Active Bookrunner on 89bio's Follow-on Offering |
~$316 |
March 16, 2023 |
Closed |
Advised LabCorp on its acquisition of Enzo Biochem’s Clinical Labs Division |
N/A |
March 14, 2023 |
Closed |
Advised RB Global on its acquisition of IAA |
~$7,000 |
March 14, 2023 |
Closed |
Advised Blackstone on its acquisition of Cvent |
~$4,600 |
March 8, 2023 |
Closed |
Acted as a Joint Bookrunner on AerCap's secondary offering by General Electric |
~$1,350 |
March 8, 2023 |
Closed |
Advised the Special Committee of Diversey on the proposed take private of Diversey by Solenis, a portfolio company of Platinum Equity |
~$4,600 |
March 7, 2023 |
Closed |
Acted as an Active Bookrunner on BridgeBio Pharmaceuticals’ Follow-on Offering |
~$151 |
March 7, 2023 |
Closed |
Advised Tidewater on its acquisition of platform supply vessels from Solstad Offshore |
$577 |
March 7, 2023 |
Closed |
Advised Advent International on its sale of Tag to Dentsu |
N/A |
March 3, 2023 |
Closed |
Acted as a Joint Bookrunner on Bumble’s Follow-on Offering |
~$314 |
March 3, 2023 |
Closed |
Advised Abra Group on its private placement |
~$1,400 |
March 2, 2023 |
Closed |
Advised IXL Learning on its acquisition of Teachers Pay Teachers |
N/A |
March 1, 2023 |
Closed |
Advised PSP on its acquisition of Radius Global Infrastructure |
~$3,000 |
February 28, 2023 |
Closed |
Advised Everfuel on the creation of a green hydrogen infrastructure joint venture with Hy24 and Hy24’s parallel equity investment into Everfuel |
€210 |
February 28, 2023 |
Closed |
Acted as a Passive Bookrunner on American Water Works Co.’s Follow-on Offering |
$1,714 |
February 28, 2023 |
Closed |
Advised abrdn on the sale of its Discretionary Fund Management Business to LGT |
£140 |
February 22, 2023 |
Closed |
Acted as an Active Bookrunner on Apellis Pharmaceuticals’ Follow-on Offering |
~$403 |
February 22, 2023 |
Closed |
Advised Tusker on its sale to Lloyds Banking Group |
~£300 |
February 21, 2023 |
Closed |
Advised Parthenon Capital on its acquisition of a majority stake in Titan Wealth |
N/A |
February 21, 2023 |
Closed |
Advised EO Charging on its capital raise from Vortex Energy and Zouk Capital |
~$80 |
February 21, 2023 |
Closed |
Advised Chesapeake Energy on the sale of a portion of its Eagle Ford assets to INEOS Energy |
~$1,400 |
February 20, 2023 |
Closed |
Advised Patrinvest on its acquisition of a minority stake in Tikehau Capital Advisors |
€400 |
February 16, 2023 |
Closed |
Advised Piedmont Lithium on its equity investment and binding offtake agreement with LG Chem |
~$75 |
February 16, 2023 |
Closed |
Advised the Ad Hoc Group of First Lien Term Loan Lenders on Yak Access’ comprehensive out-of-court restructuring |
$950 |
February 14, 2023 |
Closed |
Advised Avaya on its Restructuring via Pre-Packaged Chapter 11 bankruptcy |
~$3,400 |
February 9, 2023 |
Closed |
Acted as an Active Bookrunner on Mineralys Therapeutics’ initial public offering |
~$221 |
February 9, 2023 |
Closed |
Advised Urgently on an all-stock merger with Otonomo |
N/A |
February 8, 2023 |
Closed |
Advised Post Holdings on its acquisition of select pet brands from The J.M. Smucker Co. |
$1,200 |
February 6, 2023 |
Closed |
Acted as Greenbriar Equity Group’s exclusive global placement agent and strategic advisor for the fundraise of Greenbriar Equity Fund VI |
$3,475 |
February 3, 2023 |
Closed |
Advised Titan Acquisition Holdings, a portfolio company of The Carlyle Group and Stellex Capital Management, on its sale to Lone Star Funds |
N/A |
February 3, 2023 |
Closed |
Advised Shawn “JAY-Z” Carter on the sale of his majority interest in D’Ussé Cognac to Bacardi |
N/A |
February 2, 2023 |
Closed |
Advised Alacrity Solutions Group on a strategic investment from BlackRock Alternatives’ Long Term Private Capital |
N/A |
February 2, 2023 |
Closed |
Advised Gartner on its sale of TalentNeuron to Leeds Equity Partners |
N/A |
February 1, 2023 |
Closed |
Acted as an Active Bookrunner on Vera Therapeutics’ follow-on offering |
$115 |
February 1, 2023 |
Closed |
Advised the Conflicts Committee of the Board of Directors of Sisecam Resource Partners LLC on the sale of all outstanding common units of Sisecam Resources LP to Sisecam Chemicals Wyoming LLC |
~$131 |
January 23, 2023 |
Closed |
Advised HUTCHMED on its license with Takeda to develop and commercialize Fruquintinib outside China |
$400 upfront; +$1,130 after milestones and royalties |
January 19, 2023 |
Closed |
Advised Editas Medicine on its sale of iPSC derived iNK cell franchise to Shoreline Biosciences |
N/A |
January 18, 2023 |
Closed |
Advised Chesapeake Energy on its sale of Brazos Valley Assets to WildFire Energy |
$1,425 |
January 12, 2023 |
Closed |
Advised Areim on the establishment of its fifth value add Nordic-focused real estate fund, Areim Fund V |
€877 |
January 12, 2023 |
Closed |
Acted as a Joint Bookrunner on Expro Group Holdings follow-on offering |
$152 |
January 12, 2023 |
Closed |
Advised Lessen on its acquisition of SMS Assist |
N/A |
January 10, 2023 |
Closed |
Advised Tulchan Communications on its sale to Teneo Strategy Limited |
N/A |
January 9, 2023 |
Closed |
Advised the Special Committee of the Board of Directors of Duck Creek Technologies on its sale to Vista Equity Partners |
$2,600 |
January 9, 2023 |
Closed |
Advised TMX Group on its strategic investment in VettaFi |
$175 |
January 9, 2023 |
Closed |
Advised Nuvei on its acquisition of Paya |
$1,300 |
January 9, 2023 |
Closed |
Advised SAI360, a portfolio company of BPEA EQT, on its sale to Symphony Technology Group (STG) |
N/A |
January 6, 2023 |
Closed |
Advised Altera Infrastructure on its comprehensive restructuring and emergence from chapter 11 Bankruptcy |
~$2,060 of restructured debt + preferred equity |
January 6, 2023 |
Closed |
Advised Nucleus Group on its acquisition of Curtis Banks Group PLC |
£242 |
January 6, 2023 |
Closed |
Advised the Special Committee of DCP Midstream on Phillips 66’s Acquisition of the Public Common Units of DCP Midstream |
$3,800 |
1Announcement date for M&A transactions represents the date publicly announced; announcement date for restructurings represents the date publicly announced or filed; announcement date for capital markets transactions represents the pricing date.